Pembrolizumab and Pemetrexed for Progressive Chordoma

Clinical trial NCT06794645 · RECRUITING

Trial details

NCT number: NCT06794645
Sponsor: Saint John's Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chordomas Chordoma

Start date: 2025-01-01
Primary completion: 2026-11-30
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.